JP7902109B2 - 肺新生物形成を有する疑いのある対象におけるメチル化されたdna、rna、及びタンパク質の特性決定 - Google Patents

肺新生物形成を有する疑いのある対象におけるメチル化されたdna、rna、及びタンパク質の特性決定

Info

Publication number
JP7902109B2
JP7902109B2 JP2022513690A JP2022513690A JP7902109B2 JP 7902109 B2 JP7902109 B2 JP 7902109B2 JP 2022513690 A JP2022513690 A JP 2022513690A JP 2022513690 A JP2022513690 A JP 2022513690A JP 7902109 B2 JP7902109 B2 JP 7902109B2
Authority
JP
Japan
Prior art keywords
dna
max
methylation
marker
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022513690A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546504A (ja
JP2022546504A5 (cg-RX-API-DMAC7.html
Inventor
モーリス,スコット
マレリー,デヴィッド
ティー. アラーウィ,ハティム
ピー. リドガード,グラハム
ギアクモプロス,マリア
ダブリュー. カイザー,マイケル
エー. アールクイスト,デビッド
アール. テイラー,ウィリアム
ダブリュー. マホーニー,ダグラス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Clinic in Florida
Original Assignee
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Clinic in Florida filed Critical Mayo Clinic in Florida
Publication of JP2022546504A publication Critical patent/JP2022546504A/ja
Publication of JP2022546504A5 publication Critical patent/JP2022546504A5/ja
Priority to JP2026053590A priority Critical patent/JP2026108791A/ja
Application granted granted Critical
Publication of JP7902109B2 publication Critical patent/JP7902109B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2022513690A 2019-08-27 2020-08-27 肺新生物形成を有する疑いのある対象におけるメチル化されたdna、rna、及びタンパク質の特性決定 Active JP7902109B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026053590A JP2026108791A (ja) 2019-08-27 2026-03-27 肺新生物形成を有する疑いのある対象におけるメチル化されたdna、rna、及びタンパク質の特性決定

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962892426P 2019-08-27 2019-08-27
US62/892,426 2019-08-27
PCT/US2020/048270 WO2021041726A1 (en) 2019-08-27 2020-08-27 Characterizing methylated dna, rna, and proteins in subjects suspected of having lung neoplasia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026053590A Division JP2026108791A (ja) 2019-08-27 2026-03-27 肺新生物形成を有する疑いのある対象におけるメチル化されたdna、rna、及びタンパク質の特性決定

Publications (3)

Publication Number Publication Date
JP2022546504A JP2022546504A (ja) 2022-11-04
JP2022546504A5 JP2022546504A5 (cg-RX-API-DMAC7.html) 2023-09-01
JP7902109B2 true JP7902109B2 (ja) 2026-08-07

Family

ID=74686021

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022513690A Active JP7902109B2 (ja) 2019-08-27 2020-08-27 肺新生物形成を有する疑いのある対象におけるメチル化されたdna、rna、及びタンパク質の特性決定
JP2026053590A Pending JP2026108791A (ja) 2019-08-27 2026-03-27 肺新生物形成を有する疑いのある対象におけるメチル化されたdna、rna、及びタンパク質の特性決定

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026053590A Pending JP2026108791A (ja) 2019-08-27 2026-03-27 肺新生物形成を有する疑いのある対象におけるメチル化されたdna、rna、及びタンパク質の特性決定

Country Status (8)

Country Link
US (1) US20220403471A1 (cg-RX-API-DMAC7.html)
EP (1) EP4022093A4 (cg-RX-API-DMAC7.html)
JP (2) JP7902109B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220092856A (cg-RX-API-DMAC7.html)
CN (1) CN114945687A (cg-RX-API-DMAC7.html)
AU (1) AU2020336115B2 (cg-RX-API-DMAC7.html)
CA (1) CA3149601A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021041726A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673555B2 (en) 2008-02-15 2014-03-18 Mayo Foundation For Medical Education And Research Detecting neoplasm
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
EP2971179B1 (en) 2013-03-14 2019-01-09 Mayo Foundation for Medical Education and Research Detecting neoplasm
US10301680B2 (en) 2014-03-31 2019-05-28 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
WO2016160454A1 (en) 2015-03-27 2016-10-06 Exact Sciences Corporation Detecting esophageal disorders
JP6871926B2 (ja) 2015-08-31 2021-05-19 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチMayo Foundation for Medical Education and Research 胃の新生物を検出すること
CA3002196C (en) 2015-10-30 2024-05-14 Exact Sciences Development Company, Llc Multiplex amplification detection assay and isolation and detection of dna from plasma
US11078475B2 (en) 2016-05-03 2021-08-03 Sinai Health System Methods of capturing cell-free methylated DNA and uses of same
AU2017260630B2 (en) 2016-05-05 2023-07-13 Exact Sciences Corporation Detection of lung neoplasia by analysis of methylated DNA
AU2018211956B2 (en) 2017-01-27 2024-06-20 Exact Sciences Corporation Detection of colon neoplasia by analysis of methylated DNA
AU2018374176B2 (en) 2017-11-30 2024-12-12 Exact Sciences Corporation Detecting breast cancer
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
US12548678B2 (en) 2020-05-14 2026-02-10 Ampel Biosolutions, Llc Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus
CA3127329A1 (en) 2019-01-24 2020-07-30 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
JP7799607B2 (ja) 2019-10-31 2026-01-15 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ 卵巣癌の検出
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
AU2021257479A1 (en) 2020-04-17 2022-11-10 Exact Sciences Corporation Ingestible sampling device
WO2021228418A1 (en) 2020-05-15 2021-11-18 Universal Diagnostics, S.L. Methods and systems for identifying methylation biomarkers
US12592321B2 (en) 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
EP4150121A1 (en) 2020-06-30 2023-03-22 Universal Diagnostics, S.A. Systems and methods for detection of multiple cancer types
WO2023278528A1 (en) * 2021-07-02 2023-01-05 Enzo Biochem, Inc. Method for detecting and quantifying dna methylation in a selected locus or region of dna
CA3240200A1 (en) * 2021-12-10 2023-06-15 Scott V. BRATMAN Methods and systems for generating sequencing libraries
US20250361563A1 (en) * 2022-06-10 2025-11-27 Suzhou Huhu Health Technology Co., Ltd Methods, compositions, and kits for detecting malignant lung nodules and lung cancer
US12606872B2 (en) 2022-11-16 2026-04-21 Universal Diagnostics, S.A. Methods for stratification and early detection of advanced adenoma and/or colorectal cancer using DNA methylation markers
WO2024233363A2 (en) * 2023-05-05 2024-11-14 Foundation Medicine, Inc. Methods and systems for isolating nucleic acids
WO2025097008A2 (en) * 2023-11-01 2025-05-08 Nucleix Ltd. Mitochondrial dna intrinsic controls for use in msre-dependent dna methylation analysis
WO2025128887A1 (en) * 2023-12-13 2025-06-19 Foundation Medicine, Inc. Methods and compositions for selective enrichment of methylation signal
WO2025234733A1 (ko) * 2024-05-07 2025-11-13 주식회사 포어텔마이헬스 엑손-접합부를 포함하는 암 진단용 마커 및 레퍼런스 마커
WO2026055641A1 (en) 2024-09-06 2026-03-12 Exact Sciences Corporation Methods and compositions for preparing biomolecule analytes from complex samples

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015503356A (ja) 2012-01-06 2015-02-02 バイオミクス, インコーポレイテッドViomics, Inc. 末梢血中で、がんによって変化したrnaを検出するシステムおよび方法
US20170335401A1 (en) 2016-05-05 2017-11-23 Exact Sciences Corporation Detection of lung neoplasia by analysis of methylated dna
US20180030547A1 (en) 2011-05-02 2018-02-01 Rheinische Friedrich-Wilhelms-Universitat Bonn Blood-based gene detection of non-small cell lung cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009529329A (ja) * 2006-03-09 2009-08-20 トラスティーズ オブ ボストン ユニバーシティ 鼻腔上皮細胞の遺伝子発現プロファイルを用いた、肺疾患のための診断および予後診断の方法
EP3831954A3 (en) * 2008-11-17 2021-10-13 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
US20110318738A1 (en) * 2008-12-23 2011-12-29 University Of Utah Research Foundation Identification and regulation of a novel dna demethylase system
EP2520661A1 (en) * 2011-05-02 2012-11-07 Rheinische Friedrich-Wilhelms-Universität Bonn Blood-based gene expression signatures in lung cancer
EP2813850A1 (en) * 2013-06-10 2014-12-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting rheumatoid arthritis treatment response
WO2017181146A1 (en) * 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer
US11041214B2 (en) * 2016-05-17 2021-06-22 Genecentric Therapeutics, Inc. Methods for subtyping of lung squamous cell carcinoma
MX2021005963A (es) * 2018-11-27 2021-08-24 Exact Sciences Dev Co Llc Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180030547A1 (en) 2011-05-02 2018-02-01 Rheinische Friedrich-Wilhelms-Universitat Bonn Blood-based gene detection of non-small cell lung cancer
JP2015503356A (ja) 2012-01-06 2015-02-02 バイオミクス, インコーポレイテッドViomics, Inc. 末梢血中で、がんによって変化したrnaを検出するシステムおよび方法
US20170335401A1 (en) 2016-05-05 2017-11-23 Exact Sciences Corporation Detection of lung neoplasia by analysis of methylated dna

Also Published As

Publication number Publication date
EP4022093A1 (en) 2022-07-06
AU2020336115A1 (en) 2022-04-14
CN114945687A (zh) 2022-08-26
EP4022093A4 (en) 2024-05-22
KR20220092856A (ko) 2022-07-04
AU2020336115B2 (en) 2026-05-07
JP2022546504A (ja) 2022-11-04
US20220403471A1 (en) 2022-12-22
WO2021041726A1 (en) 2021-03-04
AU2020336115A8 (en) 2022-06-02
JP2026108791A (ja) 2026-06-30
CA3149601A1 (en) 2021-03-04

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230824

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230824

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241008

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250408

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251027

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20251216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20260327

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260630

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260728

R150 Certificate of patent or registration of utility model

Ref document number: 7902109

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150